Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecular Neurobiology|May 30, 2024
Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's DiseaseShreyasi Meur, Swarupananda Mukherjee, Souvik Roy, et al.
Current Topics in Medicinal Chemistry|September 19, 2024
PIM Kinase Inhibitors as Novel Promising Therapeutic Scaffolds in Cancer TherapyDipanjan Karati, Ankur Saha, Souvik Roy, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 1, 2024
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surfaceSakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
Current Drug Metabolism|September 25, 2025
An Explicative Review on Nanotechnology-based Drug Delivery Systems for Alleviating Oxidative Stress-driven PathologiesDipanjan Karati, Sakuntala Gayen, Swarupananda Mukherjee, et al.
AAPS Pharmscitech|May 6, 2026
Design, Optimization and Pharmacokinetic Profiling of BCS Class II Drug Loaded Oral Self Nanoemulsifying SystemAyon Dutta, Swarupananda Mukherjee, Biswajit Basu, et al.
Journal of Biochemical and Molecular Toxicology|November 6, 2025
Curcumin Mediated Ferroptosis: An Auspicious Therapeutic Avenue in Cancer TreatmentDipanjan Karati, Dhrubojyoti Sen, Beduin Mahanti, et al.
Regulatory Toxicology and Pharmacology : RTP|November 25, 2022
A toxicological evaluation for safety assessment of ruthenium-based diosmetin complex in ratsSidhanta Sil, Abhijit Das, Ishita Seal, et al.
Current Pharmaceutical Biotechnology|August 26, 2024
Current Approaches on Transfersomal Patch: A Noninvasive Innovative Booster for Improved Transdermal Drug DeliveryPiyali Khamkat, Vivek Barik, Snehamayee Mohapatra, et al.
Medical Oncology (Northwood, London, England)|April 23, 2025
Peptide-based drugs in immunotherapy: current advances and future prospectsDipanjan Karati, Shreyasi Meur, Soumi Das, et al.
Clinical and Experimental Pharmacology & Physiology|February 19, 2025
Flavokawain A Ruthenium-p-Cymene Complex-Induced Apoptosis by the Modulation of PI3K/β-Catenin/HER2/PARP Signalling in Lung CancerSakuntala Gayen, Souvik Roy, Diana Laishram, et al.
Pageof 4